More and more we are hearing from customers that they prioritize fast timelines and off-the-shelf, affordable solutions.
As a result, Aliri offers hundreds of non-proprietary, validated assays and panels that keep costs low and get meaningful data in our sponsors’ hands quickly.
With a comprehensive suite of validated, non-proprietary assays and ready-to-use immuno-focused panels, we provide cost-effective solutions with rapid turnaround times.
Our expanded NPA (Non-Proprietary Assay) list includes high-quality clinical biomarker assays ensuring reliable data for drug development.
Need a customized solution? Our team can modify existing assays—or develop entirely new biomarkers to meet your specific project requirements.